News
End-of-Phase 2 meeting with FDA requested for Alzheimer's disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback